{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:01:31Z","timestamp":1781629291036,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum M\u00fcnster"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Total neoadjuvant therapy (TNT) has demonstrated superior oncologic outcomes and improved organ preservation in randomized trials for locally advanced rectal cancer (LARC). This study aimed to assess the real-world implementation of TNT in clinical routine and identify barriers to its application.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective, multicenter cohort study analyzed 111 patients with LARC treated between February 2021 and May 2024 across three certified colorectal cancer centers in Germany. Patients were stratified into TNT and non-TNT groups according to their neoadjuvant treatment modality. Primary endpoints included treatment adherence, disease-free survival (DFS), postoperative morbidity, and documented reasons for omitting TNT. Outcomes were compared with benchmark protocols from established TNT trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Despite fulfilling guideline criteria, only 23 of 111 patients (20%) received TNT. Main barriers to TNT included advanced age, comorbidities, and patient refusal. The 1-year DFS rate was 96% in the TNT group and 94% in the non-TNT group. Severe low anterior resection syndrome (LARS) occurred in 9% of TNT patients compared to 22% in the non-TNT group. Postoperative complication rates were similar across both groups. While TNT was associated with favorable trends in disease control and functional outcomes, statistical significance was not reached.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There is a notable discrepancy between clinical guideline recommendations and real-world TNT implementation in LARC. Addressing patient-specific barriers and adopting standardized, risk-adapted treatment decision frameworks may improve clinical integration of TNT, particularly in older and comorbid populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00432-025-06412-6","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T13:55:13Z","timestamp":1767880513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Total neoadjuvant therapy for locally advanced rectal cancer: barriers to implementation in real-world practice"],"prefix":"10.1007","volume":"152","author":[{"given":"David Rene","family":"Steike","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas Benedikt","family":"Pepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Gravemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Bremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Glasbrenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Br\u00fcwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pascher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Domagk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"Biermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Theodor","family":"Eich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Reinartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"issue":"2","key":"6412_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S2468-1253(20)30333-2","volume":"6","author":"SP Bach","year":"2021","unstructured":"Bach SP, Gilbert A, Brock K, Korsgen S, Geh I, Hill J (2021) Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study. Lancet Gastroenterol Hepatol 6(2):92\u2013105","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"6412_CR2","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1016\/j.clon.2022.12.006","volume":"35","author":"SP Bach","year":"2023","unstructured":"Bach SP (2023) STAR-TREC: an international three-arm multicentre, partially randomised controlled trial incorporating an external pilot. Clin Oncol (R Coll Radiol) 35(2):e107\u2013e109","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"6412_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","volume":"22","author":"RR Bahadoer","year":"2021","unstructured":"Bahadoer RR, Dijkstra EA, Van Etten B, Marijnen CAM, Putter H, Kranenbarg EMK (2021) Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol 22(1):29\u201342","journal-title":"Lancet Oncol"},{"issue":"5","key":"6412_CR4","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1093\/annonc\/mdw062","volume":"27","author":"K Bujko","year":"2016","unstructured":"Bujko K, Wyrwicz L, Rutkowski A, Malinowska M, Pietrzak L, Kry\u0144ski J (2016) Long-course oxaliplatin-based preoperative chemoradiation versus 5 \u00d7 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study. Ann Oncol 27(5):834\u2013842","journal-title":"Ann Oncol"},{"key":"6412_CR39","unstructured":"Claus, R\u00f6del et al Short RT versus RCT,Followed by Chemo.and organ preservation for interm and High-risk rectal cancer patients [Internet]. ClinicalTrials.gov; 2024 [zitiert 3. Juni 2025] S. NCT04246684. Verf\u00fcgbar unter: https:\/\/www.clinicaltrials.gov\/study\/NCT04246684"},{"issue":"25","key":"6412_CR5","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","volume":"386","author":"A Cercek","year":"2022","unstructured":"Cercek A, Lumish M, Sinopoli J, Weiss J, Shia J, Lamendola-Essel M (2022) PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer. N Engl J Med 23 Juni 386(25):2363\u20132376","journal-title":"N Engl J Med 23 Juni"},{"issue":"5","key":"6412_CR6","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","volume":"22","author":"T Conroy","year":"2021","unstructured":"Conroy T, Bosset JF, Etienne PL, Rio E, Fran\u00e7ois \u00c9 (2021) Mesgouez-Nebout N, Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 22(5):702\u2013715","journal-title":"Lancet Oncol"},{"issue":"10","key":"6412_CR7","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.annonc.2024.06.019","volume":"35","author":"T Conroy","year":"2024","unstructured":"Conroy T, Castan F, Etienne PL, Rio E, Mesgouez-Nebout N, Evesque L (2024) Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial. Ann Oncol 35(10):873\u2013881","journal-title":"Ann Oncol"},{"issue":"1","key":"6412_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-024-03590-4","volume":"22","author":"L Correia Gomes","year":"2024","unstructured":"Correia Gomes L, Pereira BA, Miguel I, Lu\u00eds A, Pina A, Pedro C (2024) Neoadjuvant therapy in rectal cancer-one year follow-up results of standard versus total neoadjuvant strategies. World J Surg Oncol 22(1):317","journal-title":"World J Surg Oncol"},{"issue":"4","key":"6412_CR9","doi-asserted-by":"publisher","first-page":"e766","DOI":"10.1097\/SLA.0000000000005799","volume":"278","author":"EA Dijkstra","year":"2023","unstructured":"Dijkstra EA, Nilsson PJ, Hospers GAP, Bahadoer RR, Meershoek-Klein Kranenbarg E, Roodvoets AGH (2023) Locoregional failure during and after short-course radiotherapy followed by chemotherapy and surgery compared with long-course chemoradiotherapy and surgery: a 5-year follow-up of the RAPIDO trial. Ann Surg 278(4):e766\u2013e772","journal-title":"Ann Surg"},{"issue":"5","key":"6412_CR10","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1097\/SLA.0b013e31824f1c21","volume":"255","author":"KJ Emmertsen","year":"2012","unstructured":"Emmertsen KJ, Laurberg S (2012) Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer. Ann Surg 255(5):922\u2013928","journal-title":"Ann Surg"},{"issue":"2","key":"6412_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00761-023-01470-2","volume":"30","author":"M Fleischmann","year":"2024","unstructured":"Fleischmann M, Dapper H, Diefenhardt M, Martin D, Tselis N, R\u00f6del C (2024) Perkutane strahlentherapie kombiniert Mit endorektaler brachytherapie zum organerhalt Bei \u00e4lteren\/gebrechlichen patienten Mit Rektumkarzinom\u2014die ACO\/ARO\/AIO-22-Studie. Onkologie 30(2):129\u2013132","journal-title":"Onkologie"},{"issue":"1","key":"6412_CR12","doi-asserted-by":"publisher","first-page":"e215445","DOI":"10.1001\/jamaoncol.2021.5445","volume":"8","author":"E Fokas","year":"2022","unstructured":"Fokas E, Schlenska-Lange A, Polat B, Klautke G, Grabenbauer GG, Fietkau R (2022) Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer: long-term results of the CAO\/ARO\/AIO-12 randomized clinical trial. JAMA Oncol 8(1):e215445","journal-title":"JAMA Oncol"},{"issue":"34","key":"6412_CR13","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1200\/JCO.19.00308","volume":"37","author":"E Fokas","year":"2019","unstructured":"Fokas E, Allg\u00e4uer M, Polat B, Klautke G, Grabenbauer GG, Fietkau R (2019) Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO\/ARO\/AIO-12. J Clin Oncol 37(34):3212\u20133222","journal-title":"J Clin Oncol"},{"issue":"23","key":"6412_CR37","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1056\/NEJM198506063122301","volume":"312","author":"Gastrointestinal Tumor Study Group","year":"1985","unstructured":"Gastrointestinal Tumor Study Group (1985) Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 312(23):1465\u20131472","journal-title":"N Engl J Med"},{"key":"6412_CR14","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3389\/fonc.2019.00318","volume":"9","author":"C Gani","year":"2019","unstructured":"Gani C, Gani N, Zschaeck S, Eberle F, Schaeffeler N, Hehr T (2019) Organ preservation in rectal cancer: the patients\u2019 perspective. Front Oncol 9:318","journal-title":"Front Oncol"},{"issue":"4","key":"6412_CR15","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/S2468-1253(22)00392-2","volume":"8","author":"JP Gerard","year":"2023","unstructured":"Gerard JP, Barbet N, Schiappa R, Magn\u00e9 N, Martel I, Mineur L (2023) Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2\u2013cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial. The Lancet Gastroenterology & Hepatology 8(4):356\u2013367","journal-title":"The Lancet Gastroenterology & Hepatology"},{"key":"6412_CR40","unstructured":"Hofheinz RD (2023) Preoperative FOLFOX versus postoperative risk-adapted chemotherapy in patients with locally advanced rectal cancer. ClinicalTrials.gov; 2023 Nov. Report No.: NCT04495088. Verf\u00fcgbar unter: https:\/\/clinicaltrials.gov\/study\/NCT04495088"},{"issue":"3","key":"6412_CR16","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ejso.2020.01.005","volume":"46","author":"HE Haak","year":"2020","unstructured":"Haak HE, Maas M, Lambregts DMJ, Beets-Tan RGH, Beets GL, Melenhorst J (2020) Is watch and wait a safe and effective way to treat rectal cancer in older patients? Eur J Surg Oncol 46(3):358\u2013362","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"6412_CR17","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.annonc.2025.05.528","volume":"36","author":"RD Hofheinz","year":"2025","unstructured":"Hofheinz RD, Fokas E, Benhaim L, Price TJ, Arnold D, Beets-Tan (2025) R, Localised rectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol 36(9):1007\u20131024","journal-title":"Ann Oncol"},{"issue":"15","key":"6412_CR18","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1200\/JCO.21.01667","volume":"40","author":"J Jin","year":"2022","unstructured":"Jin J, Tang Y, Hu C, Jiang LM, Jiang J, Li N (2022) Multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR). J Clin Oncol 40(15):1681\u20131692","journal-title":"J Clin Oncol"},{"issue":"4","key":"6412_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041009","volume":"5","author":"CM Kensen","year":"2023","unstructured":"Kensen CM, Betgen A, Wiersema L, Peters FP, Kayembe MT, Marijnen CAM (2023) Online adaptive MRI-guided radiotherapy for primary tumor and lymph node boosting in rectal cancer. Cancers (Basel) 5(4):1009","journal-title":"Cancers (Basel)"},{"issue":"10","key":"6412_CR20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.4251\/wjgo.v7.i10.204","volume":"7","author":"M Millan","year":"2015","unstructured":"Millan M, Merino S, Caro A, Feliu F, Escuder J, Francesch T (2015) Treatment of colorectal cancer in the elderly. WJGO 7(10):204","journal-title":"WJGO"},{"issue":"3","key":"6412_CR21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ejso.2019.12.017","volume":"46","author":"AS Myint","year":"2020","unstructured":"Myint AS, G\u00e9rard JP (2020) Role of radiotherapy in the treatment of rectal cancer in older patients. Eur J Surg Oncol 46(3):349\u2013357","journal-title":"Eur J Surg Oncol"},{"key":"6412_CR38","unstructured":"National Comprehensive Cancer Network NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Rectal Cancer [Internet]. 2025 [zitiert 4. Juni 2025] S. Version 1.2025. Verf\u00fcgbar unter: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/rectal.pdf"},{"issue":"31","key":"6412_CR22","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1200\/JCO.2012.42.9597","volume":"30","author":"SY Ngan","year":"2012","unstructured":"Ngan SY, Burmeister B, Fisher RJ, Solomon M, Goldstein D, Joseph D (2012) Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: trans-tasman radiation oncology group trial 01.04. J Clin Oncol 30(31):3827\u20133833","journal-title":"J Clin Oncol"},{"issue":"2","key":"6412_CR23","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.1016\/j.ijrobp.2011.12.002","volume":"83","author":"C Ortholan","year":"2012","unstructured":"Ortholan C, Romestaing P, Chapet O, Gerard JP (2012) Correlation in rectal cancer between clinical tumor response after neoadjuvant radiotherapy and sphincter or organ preservation: 10-year results of the Lyon R 96\u2009\u2013\u200902 randomized trial. Int J Radiat Oncol* Biol* Phys 83(2):e165\u2013e171","journal-title":"Int J Radiat Oncol* Biol* Phys"},{"issue":"3","key":"6412_CR24","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/annonc\/mdu253","volume":"26","author":"D Papamichael","year":"2015","unstructured":"Papamichael D, Audisio RA, Glimelius B, De Gramont A, Glynne-Jones R, Haller D (2015) Treatment of colorectal cancer in older patients: international society of geriatric oncology (SIOG) consensus recommendations 2013. Ann Oncol 26(3):463\u2013476","journal-title":"Ann Oncol"},{"key":"6412_CR25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040694","author":"R Sauer","year":"2004","unstructured":"Sauer R, R\u00f6del C, Martus P, Hess CF, Schmidberger H (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa040694","journal-title":"N Engl J Med"},{"issue":"8","key":"6412_CR26","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1097\/DCR.0000000000000145","volume":"57","author":"AHW Schiphorst","year":"2014","unstructured":"Schiphorst AHW, Verweij NM, Pronk A, Hamaker ME (2014) Age-related guideline adherence and outcome in low rectal cancer. Dis Colon Rectum 57(8):967\u2013975","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"6412_CR27","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1056\/NEJMoa2303269","volume":"389","author":"D Schrag","year":"2023","unstructured":"Schrag D, Shi Q, Weiser MR, Gollub MJ, Saltz LB, Musher BL (2023) Preoperative treatment of locally advanced rectal cancer. N Engl J Med 389(4):322\u2013334","journal-title":"N Engl J Med"},{"issue":"1","key":"6412_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3748\/wjg.v20.i1.1","volume":"20","author":"A Sermeus","year":"2014","unstructured":"Sermeus A (2014) Advances in radiotherapy and targeted therapies for rectal cancer. WJG 20(1):1","journal-title":"WJG"},{"issue":"6","key":"6412_CR29","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/cam4.431","volume":"4","author":"H Shoji","year":"2015","unstructured":"Shoji H, Motegi M, Osawa K, Okonogi N, Okazaki A, Andou Y (2015) A novel strategy of radiofrequency hyperthermia (neothermia) in combination with preoperative chemoradiotherapy for the treatment of advanced rectal cancer: a pilot study. Cancer Med Juni 4(6):834\u2013843","journal-title":"Cancer Med Juni"},{"key":"6412_CR30","volume":"39","author":"J Steinke","year":"2023","unstructured":"Steinke J, Jordan C, Rossides S, Minnaar H, Yu J, Franklin A (2023) Planned organ preservation for elderly patients with rectal cancer using short course radiotherapy and a contact brachytherapy boost-an international multi-institution analysis. Clin Transl Radiat Oncol 39:100580","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1\u20132","key":"6412_CR31","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.canrad.2021.11.002","volume":"26","author":"V Vendrely","year":"2022","unstructured":"Vendrely V, Rivin Del Campo E, Modesto A, Jolnerowski M, Meillan N, Chiavassa S (2022) Rectal cancer radiotherapy. Cancer Radiother 26(1\u20132):272\u2013278","journal-title":"Cancer Radiother"},{"issue":"5","key":"6412_CR32","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1200\/JCO.23.01208","volume":"42","author":"FS Verheij","year":"2024","unstructured":"Verheij FS, Omer DM, Williams H, Lin ST, Qin LX, Buckley JT (2024) Long-term results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: the randomized phase II OPRA trial. JCO 42(5):500\u2013506","journal-title":"JCO"},{"issue":"12","key":"6412_CR33","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1016\/j.ejso.2021.07.018","volume":"47","author":"E Van Der Vlies","year":"2021","unstructured":"Van Der Vlies E, Vernooij LM, Van Erning FN, Vink GR, Bos WJW, Portielje JEA (2021) Survival of surgical and non-surgical older patients with non-metastatic colorectal cancer: a population-based study in the Netherlands. Eur J Surg Oncol 47(12):3144\u20133150","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"6412_CR34","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/02656736.2022.2044077","volume":"39","author":"Y Wang","year":"2022","unstructured":"Wang Y, Lu S, Shao Y, Peng R, Li X, Wang J (2022) Deep regional hyperthermia combined with modern concurrent chemoradiotherapy increases T-downstaging rate in locally advanced rectal cancer. Int J Hyperthermia 39(1):431\u2013436","journal-title":"Int J Hyperthermia"},{"issue":"5","key":"6412_CR35","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1093\/jjco\/hyy029","volume":"48","author":"CW Wee","year":"2018","unstructured":"Wee CW, Kang HC, Wu HG, Chie EK, Choi N, Park JM (2018) Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy in rectal cancer treated with neoadjuvant concurrent chemoradiation: a meta-analysis and pooled-analysis of acute toxicity. Jpn J Clin Oncol 48(5):458\u2013466","journal-title":"Jpn J Clin Oncol"},{"key":"6412_CR36","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1200\/EDBK_351411","volume":"42","author":"WH Zwart","year":"2022","unstructured":"Zwart WH, Hotca A, Hospers GAP, Goodman KA, Garcia-Aguilar J (2022) The multimodal management of locally advanced rectal cancer: making sense of the new data. Am Soc Clin Oncol Educ Book 42:264\u2013277","journal-title":"Am Soc Clin Oncol Educ Book"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06412-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-025-06412-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06412-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:19:35Z","timestamp":1781626775000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-025-06412-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["6412"],"URL":"https:\/\/doi.org\/10.1007\/s00432-025-06412-6","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This is a retrospective study. Ethical review and ap-proval were not required for the study on human participants in accordance with the local legis-lation and institutional requirements. The study was conducted according to the guidelines of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Before starting therapy, patients have given their written consent to make their data available for scientific purposes in pseudonymized form. Besides this, further individual informed consent was waived.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"31"}}